Abstract

Parkinson’s disease (PD) is a progressive neurological disorder characterized by motor and cognitive impairments due to the loss of dopamine-producing neurons. Traditional treatments focus on dopamine replacement through pharmacological means, yet these therapies have limitations and do not halt disease progression. Gene therapy presents a promising alternative by potentially modifying cellular behavior to replace lost dopamine or mitigate disease progression. This approach involves altering the function of specific genes to either restore dopamine production or correct harmful cellular activities. Current research is exploring various gene therapy techniques to improve outcomes for individuals with Parkinson’s disease, offering hope for more effective and targeted treatments.